Dengue-specific serotype related to clinical severity during the 2012/2013 epidemic in centre of Brazil
Authors:
- Benigno A. M. RochaBRBenigno A. M. Rocha
- Adriana O. GuilardeAGAdriana O. Guilarde
- Angela F. L. T. ArgoloAAAngela F. L. T. Argolo
- Marianna Peres TassaraMTMarianna Peres Tassara
- Lucimeire A. da SilveiraLSLucimeire A. da Silveira
- Isabela C. JunqueiraIJIsabela C. Junqueira
- Marília D. TurchiMTMarília D. Turchi
- Valéria C. R. FéresVFValéria C. R. Féres
- Celina M. T. MartelliCMCelina M. T. Martelli
Open Access
- 2 August 2017
- journal article
- research article
- Published by Springer Nature in Infectious Diseases of Poverty
- Vol. 6 (1) , 1-11
Abstract
Please see Additional file 1 for translations of the abstract into the five official working languages of the United Nations. Currently, in Brazil, there is a co-circulation of the four dengue (DENV-1 to DENV-4) serotypes. This study aimed to assess whether different serotypes and antibody response patterns were associated with the severity of the disease during a dengue outbreak, which occurred in 2012/2013 in centre of Brazil. We conducted a prospective study with 452 patients with laboratory confirmed dengue in central Brazil, from January 2012 to July 2013. The clinical outcome was the severity of cases: dengue, dengue with warning signs, and severe dengue. The patients were evaluated at three different moments. Blood sampling for laboratory testing and confirmatory tests for dengue infection were performed. We performed a multinomial analysis considering the three categories of the dependent variable, as outlined above. The odds ratios (ORs) were calculated. A multinomial logistic regression model was applied for variables with a P-value <0.20. Statistical analysis was performed with STATA 12.0 software. Four hundred fifty-two patients (452/632, 71.5%) were diagnosed with dengue. The dengue virus (DENV) serotypes were identified in 243 cases. DENV-4 was detected in 135 patients (55.6%), DENV-1 in 91 (37.4%), DENV-3 in 13 (5.3%), and DENV-2 in 4 (1.6%). Patients with the DENV-1 serotype were more prone to present with several clinical and laboratory features as compared with DENV-4 patients, including spontaneous bleeding (P = 0.03), intense abdominal pain (P = 0.004), neurological symptoms (P = 0.09), and thrombocytopenia (P = 0.01). Secondary infection was more predominant among DENV-4 cases (80.0%) compared with DENV-1 cases (62.3%) (P = 0.03). The univariate analysis showed that females (OR = 2.12; 95% CI: 1.44–3.13; P < 0.01) had a higher risk of having dengue with warning signs. The multinomial analysis showed that severe dengue cases with secondary infection had an adjusted OR of 2.80 (95% CI: 0.78–10.00; P = 0.113) as compared with dengue fever with primary infection when adjusted for age and sex. The current data show that 5.8% of patients recruited for treatment in healthcare centres and hospitals during the study period had severe dengue. DENV-4 was the predominant serotype, followed by DENV-1, in a large outbreak of dengue in central Brazil. Our findings contribute to the understanding of clinical differences and immune status related to the serotypes DENV-1 and DENV-4 in central of Brazil.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de Goiás
This publication has 34 references indexed in Scilit:
- Evaluation of the Diagnostic Utility of the Traditional and Revised WHO Dengue Case DefinitionsPLOS Neglected Tropical Diseases, 2013
- Evaluation of the WHO revised criteria for classification of clinical disease severity in acute adult dengue infectionBMC Research Notes, 2012
- Multicentre prospective study on dengue classification in four South‐east Asian and three Latin American countriesTropical Medicine & International Health, 2011
- Dengue Virus Serotype 4, Roraima State, BrazilEmerging Infectious Diseases, 2011
- Dengue: a continuing global threatNature Reviews Microbiology, 2010
- Dengue and Dengue Hemorrhagic Fever among Adults: Clinical Outcomes Related to Viremia, Serotypes, and Antibody ResponseThe Journal of Infectious Diseases, 2008
- Natural History of Dengue Virus (DENV)–1 and DENV‐4 Infections: Reanalysis of Classic StudiesThe Journal of Infectious Diseases, 2007
- Laboratory surveillance of dengue virus in Central Brazil, 1994–2003Journal of Clinical Virology, 2006
- Pathogenesis of Dengue: Challenges to Molecular BiologyScience, 1988
- Why dengue haemorrhagic fever in Cuba? 2. An integral analysisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1987